Latest news
Glenmark Launches Sugammadex Injection in the US Market - Machine MakerMachine Maker · Wed, 05 Aug 2026 14:16:25 GMTGlenmark eyes up to $600 Mn in revenue from new oncology launches over next 5 years - ET PharmaET Pharma · Tue, 04 Aug 2026 04:46:39 GMTGlenmark Launches Generic Sugammadex Injection in US, Targets USD 1.6 Billion Market - Medical DialoguesMedical Dialogues · Sun, 02 Aug 2026 11:16:03 GMTGlenmark Pharma Introduces Generic Sugammadex Injection In $1.6 Billion USA Market - SahiSahi · Wed, 29 Jul 2026 07:00:00 GMTGlenmark launches anesthesia reversing agent sugammadex in US - ET PharmaET Pharma · Wed, 29 Jul 2026 07:00:00 GMTGlenmark Launches Generic Sugammadex Injection in US, Expands Hospital Injectables Portfolio - eHealth MagazineeHealth Magazine · Wed, 29 Jul 2026 07:00:00 GMTGlenmark launches generic Sugammadex injection in US market - Indian Pharma PostIndian Pharma Post · Tue, 28 Jul 2026 13:00:00 GMTGlenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials - MorningstarMorningstar · Tue, 28 Jul 2026 07:00:00 GMT